HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Clinical trials for HEPATOCELLULAR CARCINOMA BY BCLC STAGE explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA BY BCLC STAGE trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA BY BCLC STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough liver cancer cases
Disease control CompletedThis study tested a drug called tislelizumab for people with advanced liver cancer (hepatocellular carcinoma) who also had moderately weakened liver function (Child-Pugh B). The goal was to see if the drug, given alone, could effectively shrink tumors and control the cancer in th…
Matched conditions: HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Researchers map Brazil's liver cancer landscape
Knowledge-focused CompletedThis study looked back at medical records of 300 Brazilian liver cancer patients treated between 2017 and 2022. Researchers analyzed how the cancer was diagnosed, what treatments patients received, and how they responded over time. The goal was to better understand liver cancer p…
Matched conditions: HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC